M2 macrophage‑derived exosomes alleviate KCa3.1 channel expression in rapidly paced HL‑1 myocytes via the NF‑κB (p65)/STAT3 signaling pathway.

Authors:
Chen H; Liu H; Liu D; Fu Y; Yao Y and 4 more

Journal:
Mol Med Rep

Publication Year: 2024

DOI:
10.3892/mmr.2024.13179

PMCID:
PMC10877089

PMID:
38334149

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Mol Med Rep

Abbreviation: Mol Med Rep

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Molecular Biology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Advances in the relationship between periodontopathogens and respiratory diseases (Review).
Zhang Z; Wen S; Liu J and 8 more (2024) - Transparency Score: 3/6
Essential contribution of the JAK/STAT pathway to carcinogenesis, lytic infection of herpesviruses …
Li W; Zhuang Y; Shao SJ and 5 more (2024) - Transparency Score: 3/6
Functional role of translocator protein and its ligands in ocular diseases (Review).
Yu M; Zhao S. (2024) - Transparency Score: 3/6
Liver sinusoidal endothelial cells as potential drivers of liver fibrosis (Review).
Gao J; Zuo B; He Y. (2024) - Transparency Score: 3/6
NLRP3 deficiency protects against acetaminophen‑induced liver injury by inhibiting hepatocyte pyrop…
Yuan X; Chen P; Luan X and 6 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"The present study was supported by the National Natural Science Foundation of China (grant nos. 81970277 and 82170312)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025